Application 203389
- Type
- NDA
- Sponsor
- HORIZON PHARMA USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PROCYSBI | CYSTEAMINE BITARTRATE | CAPSULE, DELAYED RELEASE;ORAL | EQ 25MG BASE | Yes | No |
| 002 | PROCYSBI | CYSTEAMINE BITARTRATE | CAPSULE, DELAYED RELEASE;ORAL | EQ 75MG BASE | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 75987-100 | PROCYSBI | Cysteamine bitartrate | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-100 | PROCYSBI | Cysteamine bitartrate | Horizon Pharma Inc. | NDA | Current |
| 75987-100 | PROCYSBI | Cysteamine bitartrate | Horizon Pharma Inc. | NDA | Current |
| 75987-100 | PROCYSBI | Cysteamine bitartrate | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-100 | PROCYSBI | Cysteamine bitartrate | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-100 | PROCYSBI | Cysteamine bitartrate | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-100 | PROCYSBI | Cysteamine bitartrate | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-101 | PROCYSBI | Cysteamine bitartrate | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-101 | PROCYSBI | Cysteamine bitartrate | Horizon Pharma Inc. | NDA | Current |
| 75987-101 | PROCYSBI | Cysteamine bitartrate | Horizon Pharma Inc. | NDA | Current |
| 75987-101 | PROCYSBI | Cysteamine bitartrate | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-101 | PROCYSBI | Cysteamine bitartrate | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-101 | PROCYSBI | Cysteamine bitartrate | Horizon Therapeutics USA, Inc. | NDA | Current |
| 75987-101 | PROCYSBI | Cysteamine bitartrate | Horizon Therapeutics USA, Inc. | NDA | Current |